Comparison of the Results of Lateral Anal Sphincterotomy vs Botox Injection in Patients with Chronic Anal Fissure in Terms of Pain

Kapil  Dev; Khurram  Sarfraz; Muhammad  Abdullah; Shaista  Sindhu; Sanjay Neelam  Yuvraj; Mehak  Kumari

doi:10.54112/bcsrj.v6i5.1844

Authors

Kapil Dev Department of General Surgery, Combined Military Hospital, CMH Hyderabad, Pakistan
Khurram Sarfraz Department of General Surgery, Combined Military Hospital, CMH Hyderabad, Pakistan
Muhammad Abdullah Department of General Surgery, Combined Military Hospital, CMH Hyderabad, Pakistan
Shaista Sindhu Department of General Surgery, Unit 2, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan
Sanjay Neelam Yuvraj Department of General Surgery, Combined Military Hospital, CMH Hyderabad, Pakistan
Mehak Kumari Department of General Medicine, Liaquat University of Medical & Health Sciences, Jamshoro, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v6i5.1844

Keywords:

Anal Fissure, Botulinum Toxins, Fecal Incontinence, Pain Measurement, Sphincterotomy, Subcutaneous Injections

Abstract

Chronic anal fissure is a common and painful proctologic condition that significantly impairs quality of life. While lateral internal sphincterotomy (LIS) has been the traditional gold standard treatment, concerns about complications such as faecal incontinence have prompted interest in less invasive options like botulinum toxin (BTX) injection. Objective: To compare the effectiveness of lateral internal sphincterotomy versus botulinum toxin injection in terms of pain relief among patients with chronic anal fissure. Methods: This quasi-experimental study was conducted in the Department of General Surgery at the Combined Military Hospital, Hyderabad, from October 2024 to March 2025. A total of 189 patients meeting the inclusion criteria were enrolled and divided into two groups using an odd-even number allocation method: Group A (LIS; n = 95) and Group B (BTX; n = 94). Baseline pain scores were recorded using the Visual Analogue Scale (VAS). Patients were followed up on day 7, at 1 month, and at 3 months post-intervention to evaluate pain resolution, recurrence, and faecal incontinence. Data were analyzed using SPSS version 25, and p-values <0.05 were considered statistically significant. Results: The median (IQR) age of patients in Group A was 37 (13) years, and in Group B was 38.5 (10) years. At 3 months post-intervention, pain persisted in 5 (5.3%) patients in Group A and in none (0%) in Group B (p = 0.024). Recurrence was observed in 1 (1.1%) patient in Group A compared to 13 (13.8%) in Group B (p = 0.001). Fecal incontinence occurred in 7 (7.4%) patients in Group A and 1 (1.1%) patient in Group B (p = 0.031). Conclusion: Botulinum toxin injection demonstrated superior outcomes compared to lateral internal sphincterotomy in terms of pain relief and reduced risk of fecal incontinence, although LIS was more effective in preventing recurrence. BTX may be considered a safer, less invasive alternative in the management of chronic anal fissure.

Downloads

Download data is not yet available.

References

Giani I, Cioppa T, Caminati F, Linari C, Dreoni P, Rossi G, et al. Acute and chronic anal fissure: the role of a new multitarget ointment. World J Surg Surgical Res. 2023;6:1506. https://doi.org/10.25107/2637-4625

Sabek AR, Bayan IH, Monier MI. Comparing outcomes of lateral internal sphincterotomy and laser sphincterolysis in the management of chronic anal fissure. Al-Azhar Int Med J. 2024;5(5):50.

Alvandipour M, Tavallaei M, Rezaei F, Khodabakhsh H. Postoperative outcomes of intrasphincteric botox injection during hemorrhoidectomy: a double-masked clinical trial. J Res Med Sci. 2021;26:53. https://doi.org/10.4103/jrms.JRMS_612_18

Quinn R, Jamsari G, Albayati S. Botulinum toxin injection for management of post-haemorrhoidectomy pain: an updated systematic review and meta-analysis of randomised clinical trials. Tech Coloproctol. 2025;29(1):96. https://doi.org/10.1007/s10151-025-03137-z

Tutino R, Nigro C, Paternostro F, Federico R, Lo Secco G, Gallo G, et al. Fissurectomy versus lateral internal sphincterotomy in the treatment of chronic anal fissures: no advantages in terms of post-operative incontinence. Tech Coloproctol. 2023;27(10):885–889. https://doi.org/10.1007/s10151-023-02780-8

De Robles MS, Young CJ. Real-world outcomes of lateral internal sphincterotomy vs botulinum toxin for the management of chronic anal fissures. Asian J Surg. 2022;45(1):184–188. https://doi.org/10.1016/j.asjsur.2021.06.061

Vitoopinyoparb K, Insin P, Thadanipon K, Rattanasiri S, Attia J, McKay G, et al. Comparison of doses and injection sites of botulinum toxin for chronic anal fissure: a systematic review and network meta-analysis of randomized controlled trials. Int J Surg. 2022;104:106798. https://doi.org/10.1016/j.ijsu.2022.106798

Mohsen M, Thabet W, Abdallah EE, Noor H. Unilateral Botox injection, tailored sphincterotomy in treatment of chronic anal fissure: a randomized comparative trial. Egypt J Surg. 2024;43(4):1548–1553.

Mohamed IA, Shalamesh MI, Badawy AS. Comparative study between lateral internal sphincterotomy vs. botulinum toxin injection in the treatment of chronic anal fissure. Al-Azhar Int Med J. 2023;4(10):41.

Naqvi SR, Azim MT, Luqman A, Saleem S, Malik MJ, Sarfraz K. Comparison of the postoperative outcomes of surgical lateral internal sphincterotomy and botulinum toxin injection in patients presenting with chronic anal fissure at CMH, Rawalpindi. Pak Armed Forces Med J. 2024;74(5):1420–1423.

Zangana AM, Hiwa B. A comparative study between lateral internal anal sphincterotomy and botulinum toxin injection in the treatment of chronic anal fissure. Zanco J Med Sci. 2021;25(2):513–519.

Iswariah H, Stephens J, Rieger N, Rodda D, Hewett P. Randomized prospective controlled trial of lateral internal sphincterotomy versus injection of botulinum toxin for the treatment of idiopathic fissure in ano. ANZ J Surg. 2005;75(7):553–555. https://doi.org/10.1111/j.1445-2197.2005.03445.x

Alyanak A, Gulen M, Ege B. Comparison of botulinum toxin (BoNT) injection and lateral internal sphincterotomy (redo-LIS) for recurrent anal fissure treatment. Front Surg. 2022;9:988082. https://doi.org/10.3389/fsurg.2022.988082

Khan MI, Khan H, Khan AU, Jan HU, Saeed T. Comparing the efficacy of botulinum toxin injection and lateral internal sphincterotomy for chronic anal fissure. Khyber J Med Sci. 2016;9(1):6–10.

Bonyad A, Zadeh RH, Asgari S, Eghbal F, Hajhosseini P, Ghadri H, et al. Botulinum toxin injection versus lateral internal sphincterotomy for chronic anal fissure: a meta-analysis of randomized controlled trials. Langenbeck's Arch Surg. 2024;409(1):355. https://doi.org/10.1007/s00423-023-03076-1

Brisinda G, Fico V, Tropeano G, Altieri G, Chiarello MM. Effectiveness and safety of botulinum toxin injection in the treatment of recurrent anal fissure following lateral internal sphincterotomy: cohort study. BJS Open. 2024;8(1):zrad156. https://doi.org/10.1093/bjsopen/zrad156

Rashad AM, Nafady HA, El-Gaabary TM. Comparative study between surgical lateral internal sphincterotomy and botulinum toxin injection in the treatment of chronic anal fissure. Egypt J Surg. 2020;39(4):1242–1249.

Maurice PN, Amin AR, Habeeb T, Orban YA. Comparing outcomes of lateral internal sphincterotomy, botulinum toxin injection, and laser therapy in the management of chronic anal fissure. Egypt J Hosp Med. 2023;90(2):2482–2487. doi: https://doi.org/10.21608/ejhm.2023.286029.

Cakir C, Idiz UO, Aydin I, Firat D, Ulusoy Aİ, Yazici P. Comparison of the effectiveness of two treatment modalities for chronic anal fissure: Botox versus sphincterotomy. Turk J Surg. 2020;36(3):264–270. https://doi.org/10.5578/turkjsurg.4641